Report cover image

Global Non-Invasive Liquid Biopsy Market, 2021-2027

Publisher Gen Consulting Company
Published Feb 18, 2022
Length 78 Pages
SKU # GCC16992094

Description

Global Non-Invasive Liquid Biopsy Market, 2021-2027

A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. According to market research study published by Gen Consulting Company, the global non-invasive liquid biopsy market stood at around USD 1,467 million in 2020 and is projected to rise to a worth of USD 4,072 million by 2027 end, thereby garnering a CAGR of 15.7% during 2021-2027.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global non-invasive liquid biopsy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The non-invasive liquid biopsy market is segmented on the basis of product, technology, sample, application, and application. The non-invasive liquid biopsy market is segmented as below:

By product:
  • kits and assays
  • services
By technology:
  • polymerase chain reaction (PCR)
  • sequencing
  • microarray
  • others
By sample:
  • faeces
  • urine
  • saliva
  • others
By application:
  • application
  • oncology
  • reproductive health
  • metabolic disorders
  • others
By region:
  • Asia Pacific
  • Europe
  • North America
  • Rest of the World (RoW)
The report explores the recent developments and profiles of key vendors in the Global Non-Invasive Liquid Biopsy Market, including Analytik Jena AG, EXACT Sciences Corporation, Exosome Diagnostics, Inc. (Bio-Techne Corporation), Lonza Group AG (Exosomics Siena S.p.A), MDxHealth BV, Merck KGaA, OraSure Technologies, Inc., PerkinElmer, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
  • To analyze and forecast the market size of the global non-invasive liquid biopsy market.
  • To classify and forecast the global non-invasive liquid biopsy market based on product, technology, sample, application, and application.
  • To identify drivers and challenges for the global non-invasive liquid biopsy market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global non-invasive liquid biopsy market.
  • To identify and analyze the profile of leading players operating in the global non-invasive liquid biopsy market.
Why Choose This Report
  • Gain a reliable outlook of the global non-invasive liquid biopsy market forecasts from 2021 to 2027 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.

Table of Contents

78 Pages
Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary
Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints
Part 5. Global market for non-invasive liquid biopsy by product
5.1 Kits and assays
5.1.1 Market size and forecast
5.2 Services
5.2.1 Market size and forecast
Part 6. Global market for non-invasive liquid biopsy by technology
6.1 Polymerase chain reaction (PCR)
6.1.1 Market size and forecast
6.2 Sequencing
6.2.1 Market size and forecast
6.3 Microarray
6.3.1 Market size and forecast
6.4 Others
6.4.1 Market size and forecast
Part 7. Global market for non-invasive liquid biopsy by sample
7.1 Faeces
7.1.1 Market size and forecast
7.2 Urine
7.2.1 Market size and forecast
7.3 Saliva
7.3.1 Market size and forecast
7.4 Others
7.4.1 Market size and forecast
Part 8. Global market for non-invasive liquid biopsy by application
8.1 Oncology
8.1.1 Market size and forecast
8.2 Reproductive health
8.2.1 Market size and forecast
8.3 Metabolic disorders
8.3.1 Market size and forecast
8.4 Others
8.4.1 Market size and forecast
Part 9. Global market for non-invasive liquid biopsy by region
9.1 Asia Pacific
9.1.1 Market size and forecast
9.2 Europe
9.2.1 Market size and forecast
9.3 North America
9.3.1 Market size and forecast
9.4 Rest of the World (RoW)
9.4.1 Market size and forecast
Part 10. Key competitor profiles
10.1 Analytik Jena AG
10.2 EXACT Sciences Corporation
10.3 Exosome Diagnostics, Inc. (Bio-Techne Corporation)
10.4 Lonza Group AG (Exosomics Siena S.p.A)
10.5 MDxHealth BV
10.6 Merck KGaA
10.7 OraSure Technologies, Inc.
10.8 PerkinElmer, Inc.
10.9 QIAGEN N.V.
10.10 Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us